entertainment -WSS

entertainment

author：hotspot 2025-09-27 11:29:26 - browse：6142

Daphne Koller -- biotech coverage from STAT — Daphne Koller, early biotech AI entrant Insitro's founder, CEO and board member. Courtesy Jerrick Mitra/Insitro

New artificial intelligence technologies made headlines last year for their ability to do everything from generating fake musical duets to understanding how proteins fold. But in biotech, one of the most well-funded AI players has been quiet.

Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. It raised more than $643 million in venture capital, according to PitchBook, from investors including T. Rowe Price, ARCH Venture Partners, and Casdin Capital. The company now has more than 260 employees spread out over 107,000 square feet of laboratory and office space.

But what exactly is Koller building?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Ohio train derailment: Experts on toxic chemical risks

WSS

Are embryos people? Reproductive medicine's future depends on the answer

Test for long Covid? Researchers find new clue in blood samples

Laying a path for careers in science

Readout Newsletter: Beam, Prozac, "TechBio" and more

FDA clears AI tool for detecting skin cancer

Pfizer is about to make a big push in cancer. Will investors listen?

focus

entertainment

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

Eli Lilly, Pfizer, and others want in on the online prescription market

Cancer drug shortages should be causing more outrage

Doctor of U.S. President Joe Biden says he is fit for duty

Heart attack and stroke risk calculators need revising

Francis Collins on trust in science and how Covid communications failed

In Memoriam: Notable people who died in 2023

My yearlong odyssey to get my son’s ADHD medication covered

Malaria cases in Florida and Texas: Here’s what you need to know

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

focus

Laying a path for careers in science

Humana cuts profit projections as Medicare Advantage costs soar

5 ways to address the shortage of health care workers

STAT Madness 2024: Meet the contenders

Copay coupons to count toward deductibles, after Biden court move

Are embryos people? Reproductive medicine's future depends on the answer

entertainment

knowledge

hotspot

focus